Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
- Publication date
- 10 December 2021
- Publisher
- 'Springer Science and Business Media LLC'